Search results for: 'research area cell cycle e1 enzyme'
- F1924 Anti-AXL/UFO Antibody (Tilvestamab-MMAE)Summary: Anti-AXL/UFO Antibody (Tilvestamab-MMAE)
- F1059 Anti-TSPAN26/CD37 Antibody (Lilotomab)Summary: Anti-TSPAN26/CD37 Antibody (Lilotomab)
- BA7974 AclimostatSummary: Aclimostat (ZGN-1061) is an enzyme inhibitor that has shown good efficacy and safety in preclinical studies.
- BA3146 LDCASummary: LDCA is a double-hit metabolic regulator that inhibits enzyme activity and stimulates apoptosis in malignant populations.
- BA3383 PralnacasanSummary: Pralnacasan (VX-740) is a potent, selective, non-peptide-based, orally active interleukin 1β-converting enzyme inhibitor.
- BA5190 H-Val-Pro-Pro-OHSummary: H-Val-Pro-Pro-OH, a proline peptide derivative of milk origin, is an inhibitor of angiotensin I converting enzyme
- BA2360 MensacarcinSummary: Mensacarcin is a highly complex polyketide that is commonly found in tumor cell lines to strongly inhibit cell growth and may induce apoptosis in melanoma cells.
- BA6642 GSK-5498ASummary: GSK-5498A is a selective calcium release-activated calcium channel inhibitor (1 μM).GSK-5498A inhibits mast cell mediator release and T cell pro-inflammatory cytokine release.
- F1444 Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab)Summary: Anti-NaPi2b/SLC34A2 Antibody (Lifastuzumab)
- F1643 Anti-CEACAM6/CD66c Antibody (NEO-201)Summary: Anti-CEACAM6/CD66c Antibody (NEO-201)